JNJ vs MSTY: Dividend Comparison
Dividend data as of
Johnson & Johnson (JNJ) from Health Care and Yieldmax MSTR Option Income Strategy ETF (MSTY) from N/A offer different dividend profiles for income-focused portfolios. MSTY offers a significantly higher 285.70% yield compared to JNJ's 2.16%, a gap of 283.54%. For dividend growth, JNJ leads with a 5-year CAGR of 5.2% versus MSTY's -72.8%. JNJ is a Dividend King with 63 years of consecutive increases.
Verdict
Yield Analysis
MSTY yields 283.54% more than JNJ. In dollar terms, JNJ pays $5.14/share vs MSTY's $78.13/share annually.
Dividend Growth
JNJ: Dividend growth is slowing — the 3-year CAGR of 4.6% trails the 5-year rate of 5.2% and the 10-year rate of 5.6%.
MSTY: Dividend growth has been steady, with a 3-year CAGR of -72.8% and a 5-year CAGR of -72.8% (10-year: -72.8%).
Dividend Safety
JNJ: The payout ratio of 47% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 2.1x.
Estimated Annual Dividend Income
Based on current dividend yields. Actual income may vary.
What does $10,000 buy in JNJ vs MSTY today?
At $243.53 per share, $10,000 buys about 41.1 shares of Johnson & Johnson (JNJ). Each share pays $5.14 per year in dividends, so the position starts out generating roughly $211 per year — about $18 a month.
At $24.09 per share, $10,000 buys about 415.2 shares of Yieldmax MSTR Option Income Strategy ETF (MSTY). Each share pays $78.13 per year in dividends, so the position starts out generating roughly $32,438 per year — about $2,703 a month.
MSTY is the larger income stream from day one: $32,227 per year more on the same $10,000 invested.
What could $10,000 of JNJ or MSTY income look like in 10 years?
Johnson & Johnson (JNJ) has raised its dividend about 5.2% a year over the past five years. If that pace held, the $216 per year that $10,000 generates today at the current 2.16% yield would reach $359 per year by 2036 — a 3.6% yield on the original cost.
Yieldmax MSTR Option Income Strategy ETF (MSTY)'s dividend has shrunk about 72.8% a year over the past five years. If that trend continued, today's $28,570 per year on $10,000 (at the current 285.70% yield) would fall to $0 per year by 2036.
On those trailing rates, JNJ pays more in 2036: $359 versus $0 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.
When would JNJ's dividend growth overtake MSTY's higher yield?
Johnson & Johnson (JNJ) yields less today (2.16% vs 285.70%) but has grown its dividend faster — 5.2% vs -72.8% a year over the past five years. If both trends continued, a $10,000 position in JNJ would start out-earning the same position in MSTY around 2030 (roughly 4 years from now), paying about $265 per year at the crossover. Before that point, MSTY pays more each year; after it, the gap compounds in JNJ's favor.
Why is there no payout ratio for MSTY?
REWD has neither an earnings-per-share figure nor a payout ratio for Yieldmax MSTR Option Income Strategy ETF (MSTY) — typical for ETFs and covered-call funds, whose distributions are funded by the underlying portfolio (stock dividends, option premium, or return of capital) rather than a single company's earnings. For a fund, judge sustainability by the distribution history and the strategy behind it, not a payout ratio.
Johnson & Johnson (JNJ) earns $11.03 per share against $5.14 paid out in dividends — 2.1x coverage (a 47% payout ratio). That's the usual corporate affordability test — it just doesn't translate to the fund side of this comparison.
Which fits an early-retirement income portfolio better, JNJ or MSTY?
For income you need right now, Yieldmax MSTR Option Income Strategy ETF (MSTY) leads: $100,000 invested today pays about $23,808 a month at the current 285.70% yield, versus $180 a month from Johnson & Johnson (JNJ) at 2.16%.
With a decade or more before the income is needed, JNJ's faster dividend growth (5.2% vs -72.8% a year) matters more than the starting yield — raises compound into the larger paycheck over time.
On consistency: JNJ has raised its dividend 63 consecutive years.
Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.
$10,000 with DRIP: projected annual income
If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $445/yr in JNJ vs $45,636/yr in MSTY by year 10.
Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.
Track JNJ and MSTY in your portfolio
See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan.
Frequently Asked Questions
Related Resources
Individual Stock Analysis
Dividend Tools
Track Your Dividends
More Comparisons
This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.
Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.
By using this tool you agree to our Terms of Service and Privacy Policy.